×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Mason Michael

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerSep 04, 2024Sale$0.727,0505,089391,054Sep 05, 2024, 04:24 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerJun 04, 2024Sale$0.99652645398,104Jun 06, 2024, 04:03 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 29, 2024Sale$1.1727,68732,394404,918Mar 04, 2024, 07:39 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerMar 01, 2024Sale$1.206,1627,394398,756Mar 04, 2024, 07:39 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 27, 2024Sale$1.322,5453,369244,400Feb 29, 2024, 05:35 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 06, 2024Sale$1.594,2056,671246,945Feb 08, 2024, 04:36 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerSep 01, 2023Sale$1.336,9139,203237,817Sep 05, 2023, 04:30 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerJun 02, 2023Sale$2.226311,401244,730Jun 05, 2023, 04:10 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerMar 01, 2023Sale$3.0311,20533,942245,361Mar 02, 2023, 05:30 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 06, 2023Sale$3.404,14114,079164,368Feb 08, 2023, 04:11 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO, TreasurerJun 03, 2022Sale$6.046013,630138,512Jun 06, 2022, 05:40 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 28, 2022Sale$10.242,39824,550139,110Mar 02, 2022, 03:33 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelEVP, CFO & TreasurerFeb 07, 2022Sale$9.863,94738,92553,308Feb 09, 2022, 05:25 PM
KPTIKaryopharm Therapeutics Inc.Mason MichaelSVP, CFO & TreasurerFeb 11, 2021Sale$15.522,85844,3545,292Feb 17, 2021, 06:46 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerAug 13, 2018Option Exercise$90.9544940,837563Aug 14, 2018, 06:00 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJan 04, 2018Option Exercise$88.2631,7812,804,91036,745Jan 08, 2018, 05:02 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJan 04, 2018Sale$131.5936,7454,835,17131,496Jan 08, 2018, 05:02 PM
ALKSALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 30, 2017Option Exercise$127.053,538449,5034,964Jan 03, 2018, 05:26 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerMay 16, 2017Option Exercise$14.049,375131,5879,375May 17, 2017, 06:45 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerMay 16, 2017Sale$70.009,375656,2500May 17, 2017, 06:45 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJun 01, 2015Sale$131.844,791631,6474,031Jun 03, 2015, 04:33 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJun 01, 2015Option Exercise$46.034,791220,5264,791Jun 03, 2015, 04:33 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 15, 2014Option Exercise$11.5020,625237,11722,162Dec 16, 2014, 07:07 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 15, 2014Sale$97.5022,1622,160,80813,458Dec 16, 2014, 07:07 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerFeb 03, 2014Sale$78.663,750294,9923,747Feb 04, 2014, 05:51 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TresurerJan 23, 2014Option Exercise$89.492,560229,0945,287Jan 27, 2014, 04:46 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 16, 2013Option Exercise$12.568,000100,51015,847Dec 18, 2013, 07:26 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 16, 2013Sale$60.368,000482,87210,047Dec 18, 2013, 07:26 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 02, 2013Option Exercise$7.103,75026,62511,597Dec 04, 2013, 05:01 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerDec 02, 2013Sale$61.833,750231,8639,692Dec 04, 2013, 05:01 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance & TreasurerJul 12, 2013Sale$50.0014,200710,0007,847Jul 12, 2013, 05:44 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance & TreasurerJul 12, 2013Option Exercise$31.3914,200445,73822,047Jul 12, 2013, 05:44 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJul 01, 2013Option Exercise$22.1327,000597,45022,847Jul 02, 2013, 05:32 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJul 01, 2013Sale$32.0027,000864,0007,847Jul 02, 2013, 05:32 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJun 17, 2013Option Exercise$13.6423,625322,20320,847Jun 19, 2013, 05:34 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJun 17, 2013Sale$29.9323,625707,1607,847Jun 19, 2013, 05:34 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerNov 30, 2012Sale$16.933,75063,4727,847Dec 04, 2012, 06:19 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerNov 30, 2012Option Exercise$7.103,75026,62511,597Dec 04, 2012, 06:19 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJul 27, 2012Option Exercise$10.986,25068,62514,097Jul 31, 2012, 06:13 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance and TreasurerJul 27, 2012Sale$20.006,250125,0007,847Jul 31, 2012, 06:13 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance & TreasurerJul 16, 2012Option Exercise$11.4115,295174,55416,580Jul 18, 2012, 06:02 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Mason MichaelVP, Finance & TreasurerJul 16, 2012Sale$18.5715,295284,0437,847Jul 18, 2012, 06:02 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe